Digital application to assist in the monitoring and management of sickle cell disease
Main beneficiary country:Congo - Kinshasa
Country of origin: Congo - Kinshasa
Healthcare themes targeted
Stage of development:
Area where initiative is utilised
Initiative start date
The first genetic disease in the world, Sickle Cell Disease is characterised as a rare disease or one that people are unaware of. The DRC [Democratic Republic of Congo] is the 3rd country in the world and the 2nd in Africa to bear the socio-economic burden of this disease.
In the DRC the fight against this disease is characterised by: the difficulty of obtaining precise figures; the absence of large-scale action undertaken by the State; the high cost of care ($1,000 to $2,000/disease/year); the lack of trained health personnel and infrastructures lacking the specificities of sickle cell disease (transfusion related, nutritional, surgical and orthopaedic needs, etc.); and a population that is often poorly informed.
Anemiapp therefore aims to solve the problem of caring for sickle cell patients in the city of Kinshasa.
This application brings patients in Kinshasa suffering from sickle cell disease closer to their caregivers in order to monitor their health. It facilitates the provision of treatment and access to health care. Anemiapp is also intended for the therapeutic education of sickle cell disease by mobile phones, with the patient receiving notifications on health advice and how to avoid attacks.
Telemedicine (remote diagnosis and consultations) - Information, education and communication for behaviour change (IEC) - Patient monitoring and medical data
302 Number of beneficiaries since launch
264 Number of users per Day
Health: Healthcare professionals and structures
Organizational: Communities, public authorities, NGOs, associations, foundations, etc.
Industrial: Startups, enterprises, etc.